DE602004005229D1 - Verwendung von somatostatin oder einem der analoga zur herstellung eines medikaments zur regulierung der eierstock-follikel-reserve in nicht-menopausalen frauen - Google Patents
Verwendung von somatostatin oder einem der analoga zur herstellung eines medikaments zur regulierung der eierstock-follikel-reserve in nicht-menopausalen frauenInfo
- Publication number
- DE602004005229D1 DE602004005229D1 DE602004005229T DE602004005229T DE602004005229D1 DE 602004005229 D1 DE602004005229 D1 DE 602004005229D1 DE 602004005229 T DE602004005229 T DE 602004005229T DE 602004005229 T DE602004005229 T DE 602004005229T DE 602004005229 D1 DE602004005229 D1 DE 602004005229D1
- Authority
- DE
- Germany
- Prior art keywords
- somatostatin
- menopausal women
- follicles
- regulating
- quiescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000005157 Somatostatin Human genes 0.000 title abstract 6
- 108010056088 Somatostatin Proteins 0.000 title abstract 6
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title abstract 6
- 229960000553 somatostatin Drugs 0.000 title abstract 6
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
- 230000002611 ovarian Effects 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 1
- 230000001270 agonistic effect Effects 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
- 239000001569 carbon dioxide Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003325 follicular Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03292505A EP1522311A1 (de) | 2003-10-10 | 2003-10-10 | Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau |
| EP03292505 | 2003-10-10 | ||
| PCT/FR2004/002536 WO2005034989A2 (fr) | 2003-10-10 | 2004-10-08 | Utilisation de la somatostatine ou d’un de ses analogues pour preparer un medicament destine a reguler la reserve folliculaire ovarienne chez la femme non menopausee |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE602004005229D1 true DE602004005229D1 (de) | 2007-04-19 |
| DE602004005229T2 DE602004005229T2 (de) | 2008-04-17 |
Family
ID=34307036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004005229T Expired - Lifetime DE602004005229T2 (de) | 2003-10-10 | 2004-10-08 | Verwendung von somatostatin oder einem der analoga zur herstellung eines medikaments zur regulierung der eierstock-follikel-reserve in nicht-menopausalen frauen |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7648961B2 (de) |
| EP (2) | EP1522311A1 (de) |
| JP (2) | JP5572280B2 (de) |
| AT (1) | ATE355851T1 (de) |
| CA (1) | CA2542054C (de) |
| DE (1) | DE602004005229T2 (de) |
| DK (1) | DK1680139T3 (de) |
| ES (1) | ES2284067T3 (de) |
| PL (1) | PL1680139T3 (de) |
| PT (1) | PT1680139E (de) |
| RU (1) | RU2418604C9 (de) |
| WO (1) | WO2005034989A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1522311A1 (de) * | 2003-10-10 | 2005-04-13 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau |
| JP2010538987A (ja) * | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | 治療剤としてのタフトシンの使用 |
| SI2225271T1 (sl) * | 2007-12-03 | 2013-10-30 | Italfarmaco S.P.A. | Novi selektivni analogi somatostatina |
| US20090325863A1 (en) * | 2008-06-13 | 2009-12-31 | Kleinberg David L | Somatostatin analogs and IGF-I inhibition for breast cancer prevention |
| WO2011151782A1 (en) * | 2010-06-02 | 2011-12-08 | Preglem Sa | A role for somatostatin to modulate initiation of follicular growth in the human ovary |
| US8629103B2 (en) | 2010-12-02 | 2014-01-14 | New York University | Treatment of non-proliferative cystic disease of the breast |
| EP2835136A1 (de) | 2013-08-07 | 2015-02-11 | PregLem S.A. | Somatostatin Receptor Modulator zur Unfruchtbarkeitsbehandlung |
| EP3727354A2 (de) * | 2017-12-21 | 2020-10-28 | Aarhus Universitet | Verbindungen zur verwendung in der regulierung der follikelreifung |
| RU2722849C1 (ru) | 2019-12-25 | 2020-06-04 | Владимир Глебович Лунин | Рекомбинантный белок GBD-SSTad-SSTad, способ его получения и применения |
| CN111785389B (zh) * | 2020-07-10 | 2021-10-19 | 北京大学第三医院（北京大学第三临床医学院） | 预测受试者出现卵巢储备新变化年限的系统和方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4650787A (en) * | 1985-04-25 | 1987-03-17 | Schally Andrew Victor | Biologically active octapeptides |
| MY147327A (en) | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
| JP3784418B2 (ja) * | 1996-06-11 | 2006-06-14 | ノバルティス アクチエンゲゼルシャフト | ソマトスタチン類似体およびラパマイシンの配合 |
| AU3215597A (en) * | 1996-08-30 | 1998-03-19 | Biomeasure Incorporated | Method of inhibiting fibrosis with a somatostatin agonist |
| EP0937065A1 (de) * | 1996-10-31 | 1999-08-25 | Novo Nordisk A/S | Somatostatin agonisten und antagonisten mit starrer konformation |
| GB0018891D0 (en) * | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
| NZ502796A (en) * | 2000-06-15 | 2003-02-28 | Agres Ltd | Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9 |
| JP4294959B2 (ja) * | 2001-03-06 | 2009-07-15 | ウニベルシタ・デグリ・ストゥッディ・ディ・フェラーラ | 髄様甲状腺癌の増殖を変調させる方法 |
| PL362838A1 (en) * | 2001-03-08 | 2004-11-02 | The Administrators Of The Tulane Educational Fund | Somatostatin antagonists |
| EP1522311A1 (de) * | 2003-10-10 | 2005-04-13 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau |
-
2003
- 2003-10-10 EP EP03292505A patent/EP1522311A1/de not_active Withdrawn
-
2004
- 2004-10-08 DK DK04791488T patent/DK1680139T3/da active
- 2004-10-08 JP JP2006530421A patent/JP5572280B2/ja not_active Expired - Fee Related
- 2004-10-08 RU RU2006115606/15A patent/RU2418604C9/ru not_active IP Right Cessation
- 2004-10-08 DE DE602004005229T patent/DE602004005229T2/de not_active Expired - Lifetime
- 2004-10-08 EP EP04791488A patent/EP1680139B1/de not_active Expired - Lifetime
- 2004-10-08 WO PCT/FR2004/002536 patent/WO2005034989A2/fr active IP Right Grant
- 2004-10-08 PL PL04791488T patent/PL1680139T3/pl unknown
- 2004-10-08 ES ES04791488T patent/ES2284067T3/es not_active Expired - Lifetime
- 2004-10-08 PT PT04791488T patent/PT1680139E/pt unknown
- 2004-10-08 CA CA2542054A patent/CA2542054C/fr not_active Expired - Fee Related
- 2004-10-08 US US10/575,236 patent/US7648961B2/en not_active Expired - Fee Related
- 2004-10-08 AT AT04791488T patent/ATE355851T1/de active
-
2009
- 2009-12-03 US US12/630,261 patent/US20110003749A2/en not_active Abandoned
-
2011
- 2011-07-12 JP JP2011153704A patent/JP5582477B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20070155659A1 (en) | 2007-07-05 |
| DK1680139T3 (da) | 2007-07-02 |
| CA2542054A1 (fr) | 2005-04-21 |
| WO2005034989A2 (fr) | 2005-04-21 |
| CA2542054C (fr) | 2013-11-26 |
| US20110003749A2 (en) | 2011-01-06 |
| JP5582477B2 (ja) | 2014-09-03 |
| ES2284067T3 (es) | 2007-11-01 |
| US20100152102A1 (en) | 2010-06-17 |
| JP2007508278A (ja) | 2007-04-05 |
| RU2418604C9 (ru) | 2011-07-27 |
| JP5572280B2 (ja) | 2014-08-13 |
| DE602004005229T2 (de) | 2008-04-17 |
| RU2418604C2 (ru) | 2011-05-20 |
| RU2006115606A (ru) | 2007-11-27 |
| JP2011256178A (ja) | 2011-12-22 |
| EP1680139B1 (de) | 2007-03-07 |
| ATE355851T1 (de) | 2007-03-15 |
| PT1680139E (pt) | 2007-06-12 |
| US7648961B2 (en) | 2010-01-19 |
| EP1680139A2 (de) | 2006-07-19 |
| PL1680139T3 (pl) | 2007-08-31 |
| EP1522311A1 (de) | 2005-04-13 |
| WO2005034989A3 (fr) | 2005-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004005229D1 (de) | Verwendung von somatostatin oder einem der analoga zur herstellung eines medikaments zur regulierung der eierstock-follikel-reserve in nicht-menopausalen frauen | |
| Civitelli et al. | Parathyroid hormone-related peptide transiently increases cytosolic calcium in osteoblast-like cells: comparison with parathyroid hormone | |
| KR101413686B1 (ko) | 피부줄기세포 배양방법 및 이를 이용한 피부상태 개선용 조성물 | |
| Grabbe et al. | Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells | |
| ATE292976T1 (de) | Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung | |
| JP2001526560A (ja) | 養毛方法 | |
| Swope et al. | Regulation of pigmentation in cultured skin substitutes by cytometric sorting of melanocytes and keratinocytes | |
| Franchimont et al. | Effect of mouse epidermal growth factor on DNA and protein synthesis, progesterone and inhibin production by bovine granulosa cells in culture | |
| RU2019100033A (ru) | Композиции и способы для лечения и восстановления сухожилий | |
| AR037038A1 (es) | Una composicion y metodo para alterar la masa corporal magra y las propiedades oseas en un sujeto | |
| US20190192393A1 (en) | Skin-brightening compositions and methods | |
| Veldhuis et al. | Multiplication stimulating activity regulates ornithine decarboxylase in isolated porcine granutlosa cells in vitro | |
| Harmon et al. | Evidence that activation of protein kinase A inhibits human hair follicle growth and hair fibre production in organ culture and DNA synthesis in human and mouse hair follicle organ culture | |
| CY1107756T1 (el) | Αναλογα θειου της 21-υδροξυ-6, 19-οξειδοπρογεστερονης (21oh-6οp) για τη θεραπεια πλεονασματος γλυκοκορτικοειδων | |
| DE69528473D1 (de) | Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen | |
| Jimenez et al. | The hair follicle as a wound healing promoter and its application in clinical practice | |
| Takasu et al. | Tumour promoter 12-O-tetradecanoylphorbol 13-acetate and epidermal growth factor stimulate proliferation and inhibit differentiation of porcine thyroid cells in primary culture | |
| Babül et al. | The effect of EGF application in gel form on histamine content of experimentally induced wound in mice | |
| RU2018108112A (ru) | Композиция для профилактического или терапевтического лечения состояний, связанных с изменением количества волос | |
| Koller et al. | The use of allogeneic cultivated keratinocytes for the early coverage of deep dermal burns–indications, results and problems | |
| Shew et al. | Effects of bPTH fragments (1–34),(3–34) and (7–34) on uterine contraction | |
| Kalmukova | Stem cells in nail unit of mammalians | |
| US20170252373A1 (en) | Combination therapy for the treatment of hair loss | |
| EP3559211B1 (de) | Verwendung von keimzellen zur herstellung eines mikrohaarfollikels | |
| Escobar et al. | Research Article Effect of Vitamins D and E on the Proliferation, Viability, and Differentiation of Human Dental Pulp Stem Cells: An In Vitro Study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC, FR Owner name: PREGLEM S.A., PLAN-LES-OUATES, CH |
|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: ABITZ & PARTNER, 81677 MUENCHEN |
|
| 8364 | No opposition during term of opposition |